Pulsed administration of compositions for the treatment of blood

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514538, 514546, 514563, 514568, 514576, 514578, 514629, A61K 31205, A61K 3119, A61K 3122

Patent

active

059394560

ABSTRACT:
The invention relates to novel compositions and to methods for the pulsed administration of compositions to a patient or to cells in vitro for the treatment of human blood disorders. Compositions contain chemical compounds that stimulate the expression of fetal hemoglobin and/or stimulate the proliferation of red blood cells, white blood cells and platelets in patients and ex vivo for reconstitution of hematopoiesis in vivo. These methods are useful to treat or prevent the symptoms associated with anemia, sickle cell disease, thalassemia and other blood disorders. The invention also relates to methods for the pulsed administration of compositions to patients for the treatment and prevention of cell proliferative disorders including deficiencies such as cytopenia and malignancies such as viral-induced tumors, other forms of neoplasia and for expansion of cells for hematopoietic transplantation. Pulsed administration has been shown to be more effective than continuous therapy in patients tested.

REFERENCES:
patent: 4723958 (1988-02-01), Pope et al.
patent: 4747825 (1988-05-01), Linkie et al.
patent: 4820711 (1989-04-01), Pearlman
patent: 4849426 (1989-07-01), Pearlman
patent: 4851229 (1989-07-01), Magruder et al.
patent: 4853388 (1989-08-01), Pearlman
patent: 4948592 (1990-08-01), Ayer et al.
patent: 4965251 (1990-10-01), Stamatoyannopoulos
patent: 5025029 (1991-06-01), Perrine
patent: 5366996 (1994-11-01), Elford
patent: 5403590 (1995-04-01), Forse
patent: 5635532 (1997-06-01), Samid
Abstract of ASH Annual Meeting, Seattle, Washington, Dec. 1-5, 1995; Liakopoulou et al, "Structural Features of Short Chain Fatty Acid-Derived Inducers of Fetal Hemoglobin".
Abstract of ASH Annual Meeting, Seattle, Washington, Dec. 1-5, 1995; Grossi, et al., "Effects of Monosaccharide Esters of Butyric Acid on the Synthesis of Hemoglobin T Chain an Erythroleukemia Cell Line".
Abstract of ASH Annual Meeting, Seattle, Washington, Dec. 1-5, 1995; Zituik et al., "The Silencing of .gamma.-Globin Gene Exin a .beta.-Globin Locus Yac can be Arrested by a .alpha.-Aminobutyric Acid".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pulsed administration of compositions for the treatment of blood does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pulsed administration of compositions for the treatment of blood, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pulsed administration of compositions for the treatment of blood will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-315191

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.